Dr. Marty Makary pointed out the Biden administration's decision to skip key committee meetings when authorizing vaccines, in response to a top Democrat's question.

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

The mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...

It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...

A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price ...

Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.

Dr. Jay Bhattacharya told Sen. Josh Hawley that he supports developing alternatives for vaccines and therapeutics that use aborted cell lines.

President Trump’s pick to lead the National Institutes of Health (NIH) faced questions from senators Wednesday on his plans for vaccine research, ideas for pushing down drug prices, and response ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...